Rob Young - consultant
BA DPhil CChem FRSC
I took early retirement from GSK in 2019 and set up Blue Burgundy Ltd. My 30+ years of drug discovery experience provide expertise in identifying issues and opportunities in discovery programmes, which enable my imaginative and innovative thinking to address the unique needs of every programme.
I joined Wellcome in 1990, following BA/DPhil at the University of Oxford and Post Doc at Ben May Institute, University of Chicago. Subsequent career navigated changes, mergers, and acquisitions, charting significant contributions to six development candidates in antivirals (HIV/HBV/Herpes), iNOS and Factor Xa. Moved to early stage discovery in 2006, contributing to and leading numerous successful H2L programs (HTS/Fragments/ELT).
Amongst many fruitful partnerships in international collaborations (France, Italy, Japan, Korea, USA), productive links with GSK Diseases of the Developing World group in Spain were a highlight (influential leadership in several programmes and served on SAB for EU-funded ORCHID TB consortium).
Other expertise
- Considerable expertise in Physicochemical Properties and their use in computational design. Pioneer of their use of combination with efficiency metrics to make objective benchmarking and assessments of progress
- An author/inventor on over 100 publications and patents and frequently invited speaker at international conferences, companies, and Universities. Honorary visiting lecturer, University of St Andrews since 2000, appointed Professor 2016. EPSRC college member for more than 20 years, also reviewing grants for BBSRC/MRC and experienced manuscript reviewer
- A portfolio of teaching lectures, webinars and workshops in drug discovery is available, which can be tailored to meet needs for undergraduate teaching through to continuing professional development
| Name |
Dr Rob Young |
|---|---|
| Qualifications |
BA DPhil CChem FRSC |
| Area(s) of expertise |
People Development Science, Engineering and Technology Legal and Expert Witness Services |
| Services offered |
Drug discovery and medicinal chemistry consulting Physical properties in drug design; reviews and advice Objective decision making and review of drug research programmes Independent review of licensing opportunities and due diligence Trusted expert for scientific advisory boards Patents and scientific advice relating to patent litigation Scientific input to interactions with the investment community Communication in plain language and by analogy Teaching, mentoring and professional development |
| Markets served |
Pharmaceutical companies Biotechnology companies Contract research organizations Law firms Academic groups Charitable Bodies (pro bono/expenses only services offered) |
| Geographic regions served |
Global |
| Online |